| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/03/2009 | WO2009033741A3 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 09/03/2009 | WO2009033737A3 Use of gluten exorphin c : as a therapeutic agent |
| 09/03/2009 | WO2009033731A3 Use of a laminin peptide as a therapeutic agent |
| 09/03/2009 | WO2009033723A3 Use of aip2 as a therapeutic agent |
| 09/03/2009 | WO2009033714A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009033692A3 Use of the peptides fibrinopeptide a and pyx-i as a therapeutic agents |
| 09/03/2009 | WO2009033665A3 Use of a rgd-peptide and/or parathyroid hormone (1-34 ) as anti-hiv agent |
| 09/03/2009 | WO2009033656A3 Use of follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumoniae infection |
| 09/03/2009 | WO2009030492A3 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion |
| 09/03/2009 | US20090221830 Fexofenadine Polymorphs and Processes of Preparing the Same |
| 09/03/2009 | US20090221708 Medicinal preparation |
| 09/03/2009 | US20090221703 High penetration composition and uses thereof |
| 09/03/2009 | US20090221686 Modulation of the Transcription of Pro-Inflammatory Gene Products |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221629 Drug screening; antagonizing macrophage migration inhibitory factor (MIF) using ibudilast; neuropathic pain; identifying agents useful for opiate withdrawal and for treating other addictions and dependence |
| 09/03/2009 | US20090221613 Use of Adenine-Derived Compounds for the Treatment of Lupus |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221572 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| 09/03/2009 | US20090221556 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods |
| 09/03/2009 | US20090221547 Immunosuppressant Compounds and Compositions |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090221538 Methods of treating multiple sclerosis by administering pulse dose calcitriol |
| 09/03/2009 | US20090221506 Gdnf derived peptides |
| 09/03/2009 | US20090221499 Production in E. coli of a lipidated fusion protein containing a lipidating sequence derived from Ag473 and a target polypeptide; for use in induction of immune responses |
| 09/03/2009 | US20090221487 Polyethlene glycol modifications of thymosin alpha-1 |
| 09/03/2009 | US20090221477 Linkers |
| 09/03/2009 | US20090221472 Method for treating transplant rejection |
| 09/03/2009 | US20090221077 Process for producing cytotoxic lymphocytes |
| 09/03/2009 | US20090221036 Recombinant anti-cd4 antibodies for human therapy |
| 09/03/2009 | US20090220603 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/03/2009 | US20090220550 Vaccines for Mycoplasma bovis and methods of use |
| 09/03/2009 | US20090220544 Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| 09/03/2009 | US20090220541 Emulsions with free aqueous-phase surfactant for adjuvanting split influenza vaccines |
| 09/03/2009 | US20090220533 Novel T-Helper Antigenic Determinant (THD) Peptides |
| 09/03/2009 | US20090220528 Stimulation of Toll-Like Receptors on T Cells |
| 09/03/2009 | US20090220525 Novel Bacterium and Vaccine |
| 09/03/2009 | US20090220518 Methods and compositions for treatment of graft rejection and promotion of graft survival |
| 09/03/2009 | US20090220504 Combinatorial therapy |
| 09/03/2009 | US20090220499 Agents for Suppressing Damage to Transplanted Islets After Islet Transplantation |
| 09/03/2009 | US20090220464 Mesenchymal stem cells and uses therefor |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | DE202009004878U1 Ingwer-Zusammensetzungen Ginger compositions |
| 09/03/2009 | CA2717036A1 Methods for prognosing the status of tumor patients |
| 09/03/2009 | CA2716476A1 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use |
| 09/03/2009 | CA2716400A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | CA2716396A1 Novel compositions for treatment of diseases related to activated lymphocytes |
| 09/03/2009 | CA2716366A1 Activation of innate and adaptive immune responses by a ginseng extract |
| 09/03/2009 | CA2714721A1 Anti-allergic agent |
| 09/03/2009 | CA2714500A1 Heterocyclic compounds as inhibitors of cxcr2 |
| 09/03/2009 | CA2710962A1 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereef and therapeutic application thereof |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2096438A1 Methods for prognosing the status of patients |
| 09/02/2009 | EP2094698A1 Substituted 6-phenyl-pyrido [2,3-d]pyrimidin-7-one derivatives as kinase inhibitors and methods for using the same |
| 09/02/2009 | EP2094689A2 Indolylmaleimide derivatives as kinase inhibitors |
| 09/02/2009 | EP2094662A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 09/02/2009 | EP2094306A2 Treatment of il-1-beta related diseases |
| 09/02/2009 | EP2094293A1 Tissue targeted antigenic activation of the immune response to treat cancers |
| 09/02/2009 | EP2094266A1 Crth2 antagonists |
| 09/02/2009 | EP1951282A4 Treatment of hypersensitivity |
| 09/02/2009 | EP1719516B1 A pharmaceutical composition used for treating recurrent spontaneous abortion and method thereof |
| 09/02/2009 | EP1641763B1 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | EP1091750B1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
| 09/02/2009 | EP0975597B1 Quinoline derivatives, having in particular antiviral properties, preparation and biological applications thereof |
| 09/02/2009 | EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/02/2009 | CN101519451A Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518647A Human papilloma virus preventative vaccine, construction method and application |
| 09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
| 09/02/2009 | CN101518621A Dendrobium nobile lindl capsule capable of resisting oxidation and enhancing immunity |
| 09/02/2009 | CN101518598A Tea oral tablet and preparation method thereof |
| 09/02/2009 | CN101518594A Anti-tumor immunity-enhancing traditional Chinese medicine preparation and preparation method thereof |
| 09/02/2009 | CN101518564A Application of the effective part of astragalus hoangtchy in preparation of anti-inflammatory |
| 09/02/2009 | CN101518552A Pine pollen and cyclodextrin composition, method for preparing same, use of same in preparation of health-care products for resisting fatigue and improving immunity of organisms |
| 09/02/2009 | CN101518551A Ganoderma spore oil fat emulsion and quality control method and application thereof |
| 09/02/2009 | CN101518511A Method for preparing ophthalmic preparation containing tacrolimus |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
| 09/02/2009 | CN100534529C Ordered molecular presentation of antigens, method of preparation and use |
| 09/02/2009 | CN100534436C Polynucleotide therapy |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582676 2-phenylpyran-4-one derivatives as selective COX-2 inhibitors |
| 09/01/2009 | US7582675 Flavonoid compound and process for producing the same |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582445 Anti-interferon-α antibodies |
| 09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2272540C Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 09/01/2009 | CA2210812C T-cell affecting peptides |